Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Type Segment | Volumetric pumps, Syringe pumps, Elastomeric pumps, Ambulatory/Wearable pumps, Implantable pumps |
| Application Segment | hospital inpatient oncology departments, ambulatory infusion centers, home healthcare settings, and palliative care providers |
| Technology Segment | Standard Mechanical pumps, Smart/Connected pumps, Disposable/Single-Use systems |
|---|---|
| Therapy Segment | Continuous Infusion, Intermittent (bolus) Infusion, Patient-Controlled Infusion |
| Regions & Countries |
|
The rising global cancer burden drives the market growth of chemotherapy infusion pumps The growing adoption of portable and wearable infusion devices supports the market growth of chemotherapy infusion pumps
Device-Related Risks and Patient Safety Concerns as Restraints in the Chemotherapy Infusion Pumps Market
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitive Landscape
The chemotherapy infusion pumps market is moderately consolidated, with competition primarily driven by technological differentiation, digital integration, and ease of use. Key manufacturers focus on enhancing device safety, remote operability, and compatibility with electronic health systems to meet the growing demand for patient-centric and home-based chemotherapy delivery.
Smart infusion platforms with automated programming, wireless connectivity, and cybersecurity safeguards are gaining preference among oncology care providers. As hospitals and home care systems increasingly adopt interoperable devices, players with strong digital health portfolios and scalable manufacturing capabilities maintain a competitive edge in the global market.
Recent Developments
On April 7, 2025, ICU Medical announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Plum Duo™ infusion pump, which features dual-channel delivery and a 10-inch touchscreen interface. The accompanying LifeShield software provides cloud-based drug library management and enhances interoperability across healthcare systems. The product is expected to be available in the U.S. in early 2024.
(Source: ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps | ICU Medical)
On December 14, 2023, Fresenius Kabi announced a multiyear agreement with Mayo Clinic, under which Mayo Clinic is expected to purchase 10,000 Ivenix large-volume infusion pumps for its hospitals and clinics in Minnesota, Arizona, and Florida. The Ivenix Infusion System is designed with a smartphone-like touchscreen and interfaces with hospital information systems and electronic medical records, aiming to enhance patient care through advanced technology.
(Source: Fresenius Kabi and Mayo Clinic Enter into Multiyear Supply and Service Agreement for the Ivenix® Infusion System)
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Baxter International Inc. | ••• | ••• | ••• | ••• |
| ICU Medical Inc. | ••• | ••• | ••• | ••• |
| Smiths Medical (now part of ICU Medical) | ••• | ••• | ••• | ••• |
| Fresenius Kabi AG | ••• | ••• | ••• | ••• |
| Terumo Corporation | ••• | ••• | ••• | ••• |
| B. Braun Melsungen AG | ••• | ••• | ••• | ••• |
| Moog Inc. | ••• | ••• | ••• | ••• |
| JMS Co. Ltd. | ••• | ••• | ••• | ••• |
| Avanos Medical | ••• | ••• | ••• | ••• |
| Inc.l Medical | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →According to Cognitive Market Research, the global Chemotherapy Infusion Pumps market size will be USD XX million in 2025. It will expand at a compound annual growth rate (CAGR) of XX% from 2025 to 2033.
Market Overview
According to Cognitive Market Research, the Chemotherapy Infusion Pumps market is estimated to grow at a CAGR of XX% during the forecast period. Chemotherapy infusion pumps are devices engineered to administer precise, continuous doses of chemotherapeutic agents to patients battling cancer. These pumps facilitate sustained drug release over a defined duration, helping improve therapeutic efficacy while minimizing systemic toxicity. They are utilized in hospitals, ambulatory centers, and increasingly, in home-based treatment settings.
According to the World Health Organization's International Agency for Research on Cancer, there were approximately 20 million new cancer cases worldwide in 2022, with projections indicating that this number will rise to over 35 million by 2050—a 77% increase. This surge is attributed to factors such as population ageing, growth, and increased exposure to risk factors like tobacco use, alcohol consumption, and obesity. The rising incidence of cancer underscores the need for efficient and patient-centric treatment solutions, thereby propelling the demand for chemotherapy infusion pumps that offer precise and continuous drug delivery.
Global cancer cases will jump 77% by 2050, WHO report estimates | CNN , pr345_E.pdf, Global cancer burden growing, amidst mounting need for services
Moreover, the healthcare landscape is shifting towards more decentralized models, emphasizing outpatient and home-based care. In this context, home-based care refers to the administration of medical treatments, including chemotherapy, in a patient's residence under the supervision of healthcare professionals, rather than relying on traditional hospital settings. Advancements in portable infusion technologies, such as elastomeric pumps and programmable digital systems, have facilitated this transition by enabling safe and effective chemotherapy delivery at home. These devices often integrate with electronic health records (EHRs), provide automated alerts, and support remote monitoring, aligning with modern oncology protocols that prioritize patient autonomy and real-time clinical oversight.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Chemotherapy Infusion Pumps Market Analysis is witnessing significant growth in the near future. In 2023, the Volumetric pumps segment accounted for a notable share of the Global Chemotherapy Infusion Pumps Market Analysis.Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Chemotherapy Infusion Pumps Market Analysis is witnessing significant growth in the near future.
In 2023, the Volumetric pumps segment accounted for a notable share of the Global Chemotherapy Infusion Pumps Market Analysis.
★ Reviews
Rate this report
| Type | Volumetric pumps, Syringe pumps, Elastomeric pumps, Ambulatory/Wearable pumps, Implantable pumps |
| Application | hospital inpatient oncology departments, ambulatory infusion centers, home healthcare settings, and palliative care providers |
| Technology | Standard Mechanical pumps, Smart/Connected pumps, Disposable/Single-Use systems |
| Therapy | Continuous Infusion, Intermittent (bolus) Infusion, Patient-Controlled Infusion |
| List of Competitors | Baxter International Inc., ICU Medical Inc., Smiths Medical (now part of ICU Medical), Fresenius Kabi AG, Terumo Corporation, B. Braun Melsungen AG, Moog Inc., JMS Co. Ltd., Avanos Medical, Inc.l Medical |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Chemotherapy Infusion Pumps Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Chemotherapy Infusion Pumps Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global chemotherapy infusion pumps market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.